<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="24283">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02790632</url>
  </required_header>
  <id_info>
    <org_study_id>EG-01-1962-03</org_study_id>
    <nct_id>NCT02790632</nct_id>
  </id_info>
  <brief_title>Study of EG-1962 Compared to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage</brief_title>
  <acronym>NEWTON2</acronym>
  <official_title>Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Edge Therapeutics Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Edge Therapeutics Inc</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares EG-1962 to enteral nimodipine in the treatment of aneurysmal
      subarachnoid hemorrhage.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Participant, Care Provider, Investigator, Outcomes Assessor</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of subjects with a favorable outcome measured on the Extended Glasgow Outcome Scale [Primary Efficacy Endpoint]</measure>
    <time_frame>90 Days</time_frame>
    <description>Proportion of subjects with a favorable outcome measured on the Extended Glasgow Outcome Scale (GOSE) at Day 90</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of subjects with favorable neurocognitive outcome measured by the Montreal Cognitive Assessment [Secondary Efficacy Endpoint]</measure>
    <time_frame>90 Days</time_frame>
    <description>Proportion of subjects with favorable neurocognitive outcome measured by the Montreal Cognitive Assessment (MoCA) at Day 90</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Adverse Events</measure>
    <time_frame>90 Days</time_frame>
    <description>Incidence and severity of adverse events in EG-1962 treated subjects compared to subjects treated with standard of care oral nimodipine</description>
  </other_outcome>
  <other_outcome>
    <measure>Delayed Cerebral Infarction</measure>
    <time_frame>30 Days</time_frame>
    <description>Proportion of subjects with delayed cerebral infarction present on CT scan at Day 30</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">374</enrollment>
  <condition>Subarachnoid Hemorrhage, Aneurysmal</condition>
  <arm_group>
    <arm_group_label>EG-1962 Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 dose of intraventricular EG-1962 (nimodipine microparticles) 600 mg
Up to 21 days of placebo capsules/tablets</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Enteral Nimodipine Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 dose of intraventricular normal saline
Up to 21 days of oral nimodipine capsules/tablets</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>EG-1962 (nimodipine microparticles)</intervention_name>
    <description>Single intraventricular administration of EG-1962 via EVD and placebo capsules or tablets administered for up to 21 days</description>
    <arm_group_label>EG-1962 Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Enteral Nimodipine</intervention_name>
    <description>Enteral Nimodipine capsules or tablets administered for up to 21 days and single intraventricular administration of saline via EVD</description>
    <arm_group_label>Enteral Nimodipine Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Ruptured saccular aneurysm confirmed by angiography and repaired by neurosurgical
             clipping or endovascular coiling

          2. External ventricular drain in place

          3. Subarachnoid hemorrhage on computed tomography (CT) scan of grade 2-4 on the modified
             Fisher scale

          4. WFNS grade 2, 3, or 4

        Exclusion Criteria:

          1. Major complication during aneurysm repair such as, but not limited to, massive
             intraoperative hemorrhage, brain swelling, arterial occlusion or inability to secure
             the ruptured aneurysm

          2. Angiographic vasospasm prior to randomization

          3. Evidence of a cerebral infarction with neurological deficit
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>R. Loch Macdonald, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Edge Therapeutics Inc</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alabama at Birmingham Hospital</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dignity Health; St. Joseph's Hospital and Medical Center</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85013</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of California, San Francisco-Fresno</name>
      <address>
        <city>Fresno</city>
        <state>California</state>
        <zip>93701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Keck Hospital of USC</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>David Geffen School of Medicine at UCLA</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UCSF</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Yale New Haven Hospital (YNHH)</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UF Health Shands Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baptist Medical Center/Lyerly Neurosurgery</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic Florida</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Illinois Hospital and Health Sciences System</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612-7232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Kentucky Medical Center</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Louisville Hospital</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Maryland Medical Systems</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hackensack University Medical Center</name>
      <address>
        <city>Hackensack</city>
        <state>New Jersey</state>
        <zip>07601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of New Mexico Hospital</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87131</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>North Shore University Hospital</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Icahn School of Medicine at Mount Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lenox Hill Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10075</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Rochester Medical Center</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UNC Hospitals Neuroscience Intensive Care Unit</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Pavilion</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospitals Case Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Ohio State University Wexner Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Providence St. Vincent Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97225</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oregon Health and Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jefferson Hospital for Neuroscience</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Allegheny General Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UPMC Presbyterian Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston Air Force Base</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>VCU Medical Center</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Washington, Harborview Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Alberta Hospital/Mackenzie Health Sciences Centre</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 2B7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vancouver General Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V5Z1M9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Michael's Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5B 1W8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal University Hospital</name>
      <address>
        <city>Saskatoon</city>
        <state>Saskatchewan</state>
        <zip>S7N 0W8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hadassah Hebrew University Medical Center</name>
      <address>
        <city>Jerusalem District</city>
        <state>Jerusalem</state>
        <zip>91120</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rambam Health Care Center</name>
      <address>
        <city>Haifa</city>
        <zip>3109606</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rabin Medical Center</name>
      <address>
        <city>Petah-Tikva</city>
        <zip>4941492</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edge Therapeutics</last_name>
      <email>clinicaltrials@edgetherapeutics.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>Israel</country>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 31, 2017</lastchanged_date>
  <firstreceived_date>May 26, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Aneurysm, Ruptured</keyword>
  <keyword>Nimodipine</keyword>
  <keyword>Subarachnoid Hemorrhage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Subarachnoid Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Nimodipine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
